SWOG clinical trial number
SLA01

CHARACTERIZATION OF THE EXPRESSION OF IMMUNE CHECKPOINTS IN GASTRIC CANCER FROM LATIN AMERICAN COUNTRIES

Open
Phase
Accrual
0%
Abbreviated Title
IMMUNE CHECKPOINTS IN GASTRIC CANCER FROM LATIN AMERICAN COUNTRIES
Participants
Instituto Nacional de Cancerologia (INCan), Mexico

Research committees

Gastrointestinal Cancer

Eligibility Criteria Expand/Collapse

a. Gastric carcinoma diagnosis and surgical resection

b. Patient must have 2 years minimum of follow-up after surgery or have died within two years after surgery.

c. Patients must have previously submitted their tissue for specimen banking at their local institution AND must have previously consented to their samples being used in future research.

d. Specimen requirements:
i. FFPE malignant primary tumor tissue from surgical resection, prior to chemotherapy, obtained within the last 5 years.
ii. The paraffin block or blocks sent should have enough tumor tissue to take at least three cores of tissue each three millimeters in diameter.
iii. At least one paraffin tumor block should remain at the institution enrolling the patient.